Hyaluronic acid conjugates and uses thereof
AssigneeUniversite De Geneve
InventorsPierre Maudens, Eric Allemann, Olivier Jordan
Life of this patent
Estimating the term…
Abstract
The present invention is directed to new graft polymer of a hyaluronic acid polymer and N-isopropylacrylamide based polymer, preparations, compositions and uses thereof. In particular, the invention relates to pH and/or thermo-sensitive compositions able to form spontaneously nanoparticles useful as active and agents and delivery systems for at least one bioactive agent.
Claims24
A graft polymer of a hyaluronic acid polymer and a N-isopropylacrylamide based polymer wherein the hyaluronic acid polymer and the N-isopropylacrylamide based are conjugated through at least one linker L of Formula (II):
- wherein one of Ra and Rb is covalently linked to the N-isopropylacrylamide based polymer and one of Ra and Rb is covalently linked to the hyaluronic acid polymer and when Ra or Rb is covalently linked to the N-isopropylacrylamide based polymer, it is equal to R1 and when Ra or Rb is covalently linked to the hyaluronic acid polymer, it is equal to R3, wherein R1 is a group selected from (CH2)x—NH(CH2)y—S—, —(CH2)x—NH—O—C(O)—(CH2)y—S—, —(CH2)x—NH—(CH2)y—C(O)—NH—(CH2)z—S—, —(CH2)x—O—C(O)—CR7R8—, —C(O)—(CH2)x—C(O)—NH—(CH2)z—S and an optionally substituted polyethylene chain wherein R7 and R8 are optionally substituted C1-C6 alkyl;
- R3 is a group -E-G-L1- wherein E is either absent or selected from —C(O)—NR9—, —C(O)—O— and —C(O)—, G is linker group selected from optionally substituted C1-C20 alkyl, optionally substituted polyethylene glycol (PEG) chain, optionally substituted acylamino C1-C6 alkyl, optionally substituted acyl C1-C6 alkyl, optionally substituted aminocarbonyl C1-C6 alkyl and optionally substituted C1-C6 alkoxy and L1 is selected from —NR10C(O)—, —C(O)—NR10—, —C(O)—O— and —C(O)— wherein R9 and R10 are independently selected from H and optionally substituted C1-C6 alkyl;
- A is an optionally substituted C5-C10-cycloalkyl, or optionally substituted heterocycloalkyl ring wherein R5 represents one or more substituent(s) independently selected from H, optionally substituted alkoxy and optionally substituted C1-C6 alkyl;
- x, y and z are integers independently selected from 1 to 20 or any pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.